» Articles » PMID: 38753060

Qualitative Exploration of Sexual Dysfunction and Associated Coping Strategies Among Iranian Prostate Cancer Survivors

Overview
Specialties Critical Care
Oncology
Date 2024 May 16
PMID 38753060
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our understanding of the experiences of prostate cancer survivors regarding their sexual life and related issues remains limited. Therefore, this study aimed to explore sexual dysfunction and associated coping strategies among Iranian prostate cancer survivors.

Methods: A qualitative study was undertaken. Participants were 15 Iranian prostate cancer survivors chosen using purposeful sampling. Data collection involved conducting in-depth semi-structured interviews, followed by the utilization of the conventional qualitative content analysis method for data analysis.

Results: Three themes were developed: (a) suspension of sexual life-treatment for prostate cancer significantly impacted participants' sexual lives; (b) emotional resilience and psychological coping strategies-various psychological strategies were used to tackle sexual dysfunction; (c) efforts to regain sexual function-several strategies were applied to enhance sexual performance.

Conclusion: Our study findings provide insights into the experiences of prostate cancer survivors and subsequent shifts in their sexual dynamics and coping with the disease. Healthcare providers should actively identify patients' concerns and develop culturally tailored care strategies to address sexual challenges and improve coping among prostate cancer survivors.

Citing Articles

Cross-Cultural Adaptation and Pilot Psychometric Validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire-Sexual Health (EORTC QLQ-SH22) Scale, Moroccan Arabic Version.

Mahlaq S, Rais G, Abouqal R, Belayachi J Healthcare (Basel). 2024; 12(18).

PMID: 39337233 PMC: 11431793. DOI: 10.3390/healthcare12181892.

References
1.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

2.
Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

3.
Donovan J, Hamdy F, Lane J, Mason M, Metcalfe C, Walsh E . Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med. 2016; 375(15):1425-1437. PMC: 5134995. DOI: 10.1056/NEJMoa1606221. View

4.
Nicolai M, Urkmez A, Sarikaya S, Fode M, Falcone M, Albersen M . Penile Rehabilitation and Treatment Options for Erectile Dysfunction Following Radical Prostatectomy and Radiotherapy: A Systematic Review. Front Surg. 2021; 8:636974. PMC: 7961076. DOI: 10.3389/fsurg.2021.636974. View

5.
Edmunds K, Tuffaha H, Galvao D, Scuffham P, Newton R . Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review. Support Care Cancer. 2020; 28(5):2079-2093. DOI: 10.1007/s00520-019-05255-5. View